Aggressive Management in A Child With Homozygous Familial Hypercholesterolemia

Osman Başpınar; Hakkı Kazaz; Bahadır Dağlar; Ziya Bayraktaroğlu; Vedat Davutoğlu; Alper İ. Dai

doi:10.58600/eurjther.2009-15-1-1263-arch

Authors

Osman Başpınar Gaziantep University School Of Medicine Department Of Pediatrics
Hakkı Kazaz Gaziantep University School Of Medicine Department Of Cardiovascular Surgery
Bahadır Dağlar Gaziantep University School Of Medicine Department Of Cardiovascular Surgery
Ziya Bayraktaroğlu Gaziantep University School Of Medicine Department Of Pediatrics
Vedat Davutoğlu Gaziantep University School Of Medicine Department Of Cardiology
Alper İ. Dai Gaziantep University School Of Medicine Department Of Pediatrics

DOI:

https://doi.org/10.58600/eurjther.2009-15-1-1263-arch

Keywords:

Familial hypercholesterolemia, Child, Apheresis, Coronary bypass, Ezetimibe

Abstract

Homozygous familial hypercholesterolemia is a rare and fatal disease. Twelve year-old girl patient with anginal symptoms and diffuse xanthomas were treated with diet restriction, per oral high dose statins, ezetimibe, low-density lipoprotein cholesterol apheresis and coronary artery bypass grafting. She has been on follow-up visit in stable condition.

Metrics

Metrics Loading ...

References

Starc TJ. Management of hyperlipidemia in children. Prog Pediatr Cardiol. 2001;12:205-213.

Rallidis L, Naoumova RP, Thompson GR, Nihoyannopoulos P. Extent and severity of atherosclerotic involvement of the aortic valve and root in familial hypercholesterolaemia. Heart. 1998;80:583-590.

Keller C, Schmitz H, Theisen K, Zollner N. Regression of valvular aortic stenosis due to homozygous familial hypercholesterolemia following plasmapheresis. Klin Wochenschr. 1986;64:338-341.

Gagne C, Gaudet D, Bruckert E; Ezetimibe Study Group. Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia. Circulation. 2002;105:2469- 2475.